Palantir’s Valuation Conundrum Amid a Flurry of Government Contracts

Palantir Technologies finds itself in a familiar position: securing massive government contracts while Wall Street debates whether its stock price has run too far, too fast. The data analytics firm recently landed an exclusive $300 million deal with the U.S. Department of Agriculture (USDA), its third major federal contract within 90 days. Yet, the shares remain nearly 10% down year-to-date, trading significantly below their November 2025 peak of 179.86 euros.

The USDA contract, awarded Wednesday, aims to modernize outdated IT systems and consolidate data for American farmers under the National Farm Security Action Plan. Central to the initiative is the “One Farmer, One File” project, which will unify fragmented systems from the Farm Service Agency, the Natural Resources Conservation Service, and the Risk Management Agency onto a single platform. Full implementation is targeted for 2028. Palantir’s Landmark platform will serve as the technical foundation, having already proven its capability in February 2026 by processing $4.4 billion in payments from the Farmer Bridge Assistance Program within five days. The company emphasized the project remains internal to the USDA, with no cross-agency data sharing or surveillance components planned.

This deal underscores the growing political urgency around food security, heightened by elevated fertilizer prices stemming from Middle East conflicts and persistent trade disputes. It adds to a robust government foundation that includes a multi-billion dollar umbrella contract with the U.S. Army, consolidating 75 individual agreements. Palantir is also currently bidding for an AI tool contract as part of the Federal Aviation Administration’s (FAA) $32 billion modernization program.

Financially, the business appears robust. For the fourth quarter of 2025, Palantir reported revenue of $1.41 billion, a 70% year-over-year increase. Its U.S. commercial customer segment grew by an impressive 137%. Management has guided for full-year 2026 revenue exceeding $7.1 billion. The stock reacted positively to the USDA news, gaining approximately 3.9% to 129.08 euros in Frankfurt trading.

Should investors sell immediately? Or is it worth buying Palantir?

However, the valuation remains a persistent concern. Even after recent pullbacks, the stock trades at roughly 64 times estimated 2027 free cash flow. The price-to-earnings ratio is cited between 117 and 231, depending on the calculation method, leaving little room for operational missteps. Analyst opinions reflect this tension. Wedbush maintains an “Outperform” rating with a $230 price target, with analyst Daniel Ives recently dismissing competitive fears from Anthropic as a “fictional narrative.” Conversely, Mizuho analyst Gregg Moskowitz recently lowered his price target from $195 to $185, citing mixed demand signals in the software sector, though he kept an “Outperform” rating. Morgan Stanley holds a neutral stance with a $205 target.

Investor sentiment is mixed. While a major shareholder increased their position by nearly 5% in Q4 2025, PFG Advisors reduced its stake by 29.2% in the same period. In February, CEO Alexander Karp and other executives sold shares worth approximately $137.7 million.

All eyes now turn to the company’s upcoming first-quarter earnings report on May 4, 2026. Analysts expect earnings per share of $0.26 on revenue of $1.54 billion. The results will be a critical test of whether Palantir’s explosive growth momentum can continue to justify its premium valuation amidst a challenging macro environment of persistent inflation and high interest rates.